๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A comparison of nitrogen mustard, vincristine, procarbazine, and prednisone (mopp) vs. nitrogen mustard in advanced hodgkin's disease

โœ Scribed by Charles M. Huguley Jr; John R. Durant; Russell R. Moores; Yick-Kwong Chan; Ronald F. Dorfman; Lorraine Johnson


Publisher
John Wiley and Sons
Year
1975
Tongue
English
Weight
1016 KB
Volume
36
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Long-term remission in hodgkin's disease
โœ Joseph M. Kiely; Edgar G. Harrison JR. ๐Ÿ“‚ Article ๐Ÿ“… 1970 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 762 KB

A patient with Hodgkin's disease (Stage IIB) was given nitrogen mustard shortly after diagnosis and has survived, without recurrence, for more than 5 years. HFhfOTHERAPY FOR CANCER IS OFTEN OF C palliative benefit but is only rarely curative. Single-agent chemotherapy4, 5 , 9 has achieved cure rate

Treatment of Hodgkin's disease in childr
โœ van den Berg, Henk; Stuve, Wouter; Behrendt, Henk ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 108 KB ๐Ÿ‘ 2 views

Since the introduction of mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) chemotherapy, children with Hodgkin's disease (HD) have been treated with chemotherapy alone. The occurrence of side effects related to irradiation (especially secondary solid tumors) is less likely to occur.